Xavier Health Represented in Capitol Hill Panel on AI

The U.S. Capitol

Dr. Marla Phillips, Director, Xavier Health, took part in a panel discussion on Capitol Hill, July 17, 2018. The event, titled “AI Explainability: What that Means and Why It Matters in Healthcare,” was organized by IBM, moderated by Zach Rothstein from Advamed Digital Health and included Phillips, representing the Xavier AI Initiative, along with Bakul Patel, FDA, Dr. Anil Jain, IBM Watson Health, and Dr. Michael Hodgkins, American Medical Association. The panel discussed what AI explainability means and how AI can transform healthcare to keep patients safe. Through the Xavier AI Initiative, Xavier, FDA, and AdvaMed are working to advance the predictive capabilities of AI in pharmaceutical and medical device manufacturing, quality operations, and regulatory affairs.

  Rep. John Delaney addresses the AI panel.   [L to R:  Marla Phillips, Ph.D. (Xavier Health); Bakul Patel (FDA); Michael Hodgkins, M.D. (AMA); Anil Jain, Ph.D. (IBM); Rep. John Delaney (D-MD).]

Rep. John Delaney addresses the AI panel. [L to R:  Marla Phillips, Ph.D. (Xavier Health); Bakul Patel (FDA); Michael Hodgkins, M.D. (AMA); Anil Jain, Ph.D. (IBM); Rep. John Delaney (D-MD).]

Representative John Delaney (D-MD) addressed the standing room only session with a strong message of collaboration. As co-chair of the House AI Caucus, he emphasized the criticality of bringing government, industry and others together to advance the possibilities of health care through the power of AI. Delaney acknowledged that each panel member represents a cross-section of organizations already working collaboratively for the betterment of personal health. Xavier Health is leading AI initiatives that include all panel member organizations and the pharmaceutical and medical device industries.

Also joining the discussion were Representative Doris Matsui (D-CA) and Representative Larry Bucshon (R-IN), both of whom recognized the importance of collaboration across critical stakeholders.

The representatives are working to increase careers within AI and technology, overcome unmet healthcare needs, and maintain the United States’ position as a world leader in technology. During the panel, Xavier was recognized as leading collaborative innovation with these stakeholders.

This panel came within weeks of the second Xavier AI Summit, Aug. 23-24, which will provide participants with insight on AI in action while providing purpose-driven foundational sessions. Google, Microsoft, IBM and Dell are all involved in Xavier Health’s work.

  The Rayburn House Office Building, southwest of the U.S. Capitol, where the panel discussion was held.

The Rayburn House Office Building, southwest of the U.S. Capitol, where the panel discussion was held.